Liqun Zou
-
- Lymphoma Diagnosis and Treatment 65
- Oncology top 5%
- Viral-associated cancers and disorders 29
- CAR-T cell therapy research 9
-
- Immune Cell Function and Interaction 14
- Neurology top 10%
- CNS Lymphoma Diagnosis and Treatment 16
-
- Chronic Lymphocytic Leukemia Research 8
-
- Cardiac tumors and thrombi 7
-
- Lung Cancer Treatments and Mutations 7
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Liqun Zou
102 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 114
- Pathology and Forensic Medicine 445
- Oncology 499
- Immunology 209
- Neurology 106
- Genetics 73
Countries citing papers authored by Liqun Zou
This map shows the geographic impact of Liqun Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liqun Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liqun Zou more than expected).
Fields of papers citing papers by Liqun Zou
This network shows the impact of papers produced by Liqun Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liqun Zou. The network helps show where Liqun Zou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Liqun Zou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 10 | |
| 6 | 2024 | 2 | |
| 7 | 2023 | 0 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 7 | |
| 10 | 2023 | 6 | |
| 11 | 2023 | 9 | |
| 12 | 2023 | 1 | |
| 13 | 2023 | 3 | |
| 14 | 2023 | 4 | |
| 15 | 2022 | 12 | |
| 16 | 2022 | 3 | |
| 17 | 2021 | 4 | |
| 18 | 2020 | 1 | |
| 19 | 2019 | 7 | |
| 20 | 2009 | 81 |
About Liqun Zou
Liqun Zou is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics, having authored 116 papers that have together received 1.0k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (65 papers), Viral-associated cancers and disorders (29 papers), CNS Lymphoma Diagnosis and Treatment (16 papers), Immune Cell Function and Interaction (14 papers), CAR-T cell therapy research (9 papers), Chronic Lymphocytic Leukemia Research (8 papers), Cardiac tumors and thrombi (7 papers) and Lung Cancer Treatments and Mutations (7 papers). The work is most often cited by research in Pathology and Forensic Medicine (445 citations), Oncology (499 citations) and Immunology (209 citations). Liqun Zou has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Ming Jiang, Yu Jiang, Sha Zhao, Weiping Liu, Xi Yan, Feng Luo, Mei Li, Wenyan Zhang, Li Xie and Qun‐pei Yang. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.